Latest Breaking News On - Craiga portell - Page 1 : comparemela.com

New combination treatment offers hope for older patients with mantle cell lymphoma

The phase 2 trial PrE0405 met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients over the age of 60 with mantle cell lymphoma (MCL) who received bendamustine and rituximab, a standard chemo-immunotherapy treatment, along with venetoclax, which is investigational in this setting.

San diegoUnited statesCraiga portellUniversity of virginia comprehensive cancer centerAmerican society of hematologyMember of the roche groupAmerican societyVirginia comprehensive cancerFederal recordMantle cell lymphomaBone marrowHodgkin lymphomaNon hodgkin lymphoma

PrECOG Trial: Venetoclax Plus Chemo-Immunotherapy Effective in Treating Mantle Cell Lymphoma

PrECOG Trial: Venetoclax Plus Chemo-Immunotherapy Effective in Treating Mantle Cell Lymphoma
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoCraiga portellUniversity of virginia comprehensive cancer centerAmerican society of hematologyAmerican societyVirginia comprehensive cancerFederal record

Anonymous $5 75 million gift will enable UVA to fight against rare blood cancers

A gift of more than $5.75 million from anonymous donors will allow UVA Cancer Center to speed the development of new treatments for rare blood cancers and provide more patients with these cancers access to cutting-edge clinical trials.

United statesCraiga portellOwena oconnorK craig kentThomasp loughran jrEmily hendersonMichaele williamsEnrica marchiDavidj feithCancer centersNational cancer instituteCancer centerUniversity of virginiaTranslational orphan blood cancer research initiative fundNational cancer comprehensive centerAmerican cancer society research professor